What is the best course of treatment for a 54-year-old male patient with onychomycosis, subungual hematomas, and a history of a bloody blister on the toes, currently being treated with CeraVe (moisturizer) cream, Epsom salt foot baths, and terbinafine (antifungal medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Onychomycosis in a 54-Year-Old Male Patient

Terbinafine 250 mg daily for 12 weeks is the optimal treatment for this patient's toenail onychomycosis, as it has superior efficacy compared to other antifungal medications with cure rates of 70-80% for toenail infections. 1

Evaluation of Current Treatment Plan

The current treatment plan includes:

  • Daily terbinafine for three months
  • Epsom salt foot baths for 10 minutes nightly
  • CeraVe cream for moisturizing

Appropriateness of Systemic Therapy

The presence of multiple affected toenails with onychomycosis warrants systemic therapy. The British Association of Dermatologists guidelines strongly support this approach:

  1. Terbinafine is the first-line treatment for dermatophyte onychomycosis based on:

    • Higher efficacy compared to itraconazole (55% vs 26% complete cure at 72 weeks) 1
    • Lower relapse rates (23% vs 53% for itraconazole) in long-term follow-up 1
    • Fungicidal (rather than fungistatic) activity against dermatophytes 1
  2. Dosing regimen:

    • 250 mg daily for 12-16 weeks for toenail infections 1
    • Continuous daily dosing is superior to pulse dosing 2

Management of Subungual Hematomas

The patient also has subungual hematomas on the right and left 3rd toenails. These should be addressed separately from the onychomycosis:

  • Monitor for resolution as these typically resolve on their own as the nail grows out
  • If painful or causing significant discomfort, consider nail trephination to relieve pressure
  • Ensure proper footwear to prevent further trauma

Comprehensive Treatment Algorithm

  1. Confirm diagnosis (ideally should be done before starting treatment)

    • Microscopy and culture should be performed before initiating therapy 1
    • This is particularly important as treatment failure may occur if the causative organism is not a dermatophyte
  2. Systemic therapy

    • Continue terbinafine 250 mg daily for 12 weeks as prescribed
    • Monitor for potential side effects:
      • Gastrointestinal symptoms (49% of cases): nausea, diarrhea, taste disturbance 1, 3
      • Dermatological reactions (23% of cases): rash, pruritus, urticaria 1
      • Rare but serious: hepatotoxicity, Stevens-Johnson syndrome 1, 3
  3. Adjunctive measures

    • Continue Epsom salt foot baths as they help soften the nail and may improve penetration of topical agents
    • Continue CeraVe cream for skin hydration, which has already helped resolve the bloody blister
    • Consider mechanical debridement of affected nails if they are thickened, as this may improve treatment outcomes
  4. Monitoring

    • Re-evaluate after 3-6 months from treatment initiation 1
    • Further treatment should be given if the disease persists
    • Complete nail regrowth may take 12-18 months even after successful treatment

Important Considerations and Potential Pitfalls

  1. Baseline laboratory testing

    • Consider baseline liver function tests and complete blood count, especially if the patient has:
      • History of heavy alcohol consumption
      • Pre-existing liver disease
      • History of hepatitis 1, 3
  2. Drug interactions

    • Terbinafine has minimal drug-drug interactions compared to azoles 1, 4
    • Main interaction is with drugs metabolized by cytochrome P450 2D6 isoenzyme 1
  3. Treatment failure considerations

    • If treatment fails, consider:
      • Poor compliance
      • Poor absorption
      • Immunosuppression
      • Dermatophyte resistance
      • Subungual dermatophytoma preventing drug penetration 1
    • In cases of treatment failure, either an alternative drug or partial nail removal in combination with further therapy may be necessary 1
  4. Patient education

    • Warn about potential taste disturbance, which can be permanent in rare cases 1, 3
    • Advise to report any symptoms of liver problems immediately (nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice) 3
    • Minimize sun exposure as terbinafine can cause photosensitivity 3

The combination of systemic terbinafine with appropriate foot care (Epsom salt soaks and moisturizing) represents an evidence-based approach to treating this patient's onychomycosis while addressing the resolved bloody blister and monitoring the subungual hematomas.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Terbinafine: a review of its use in onychomycosis in adults.

American journal of clinical dermatology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.